Who invested in Hinova Pharma?
Hinova Pharma's investors include GF Xinde Investment Management, Hermed Capital and Fosun Capital.
China · Series C startup
Funding summaryUpdated 26 Oct 2026
$187Mraised across 2 rounds since 2019, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Hinova Pharma's investors include GF Xinde Investment Management, Hermed Capital and Fosun Capital.
Hinova Pharma has raised $187M across 2 rounds since 2019.
Hinova Pharma's most recent round was a Series C of $147M in Oct 2020.
Its most recent round, $147M in Oct 2020, is also its largest on record.
Hinova Pharma's first round on record, in Jul 2019, was backed by Hermed Capital and Fosun Capital.
Hinova Pharma's latest named round is a Series C, in Oct 2020.
Hinova Pharma is based in China.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.